{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:01:56Z","timestamp":1793505716941,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ajem.2020.11.039","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T10:01:28Z","timestamp":1606039288000},"page":"585-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department"],"prefix":"10.1016","volume":"46","author":[{"given":"Patrick","family":"McGrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya R.","family":"Chilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajem.2020.11.039_bb0005","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1197\/j.aem.2007.01.013","article-title":"U.S. emergency department visits for supraventricular tachycardia, 1993\u20132003","volume":"14","author":"Murman","year":"2007","journal-title":"Academic Em Med"},{"issue":"1","key":"10.1016\/j.ajem.2020.11.039_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.annemergmed.2007.03.007","article-title":"Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004","volume":"51","author":"Mcdonald","year":"2008","journal-title":"Annals of Em Med"},{"issue":"8","key":"10.1016\/j.ajem.2020.11.039_bb0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.ajem.2020.11.039_bb0020","author":"Centers for Disease Control and Prevention"},{"issue":"21","key":"10.1016\/j.ajem.2020.11.039_bb0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"64","author":"January","year":"2014","journal-title":"JACC."},{"key":"10.1016\/j.ajem.2020.11.039_bb0030","series-title":"Diltiazem Hydrochloride [package insert]","year":"2007"},{"key":"10.1016\/j.ajem.2020.11.039_bb0035","series-title":"Metoprolol Tartrate [package insert]","year":"2008"},{"issue":"15","key":"10.1016\/j.ajem.2020.11.039_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ajem.2020.11.039_bb0045","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2146\/ajhp160126","article-title":"Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department","volume":"73","author":"Hines","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.ajem.2020.11.039_bb0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan","year":"2005","journal-title":"Em Med J"},{"issue":"2","key":"10.1016\/j.ajem.2020.11.039_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J Em Med"},{"key":"10.1016\/j.ajem.2020.11.039_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MEJ.0000000000000227","article-title":"B-blockers versus calcium channel blockers for acute rate control of atrial fibrillation with rapid ventricular response: a systematic review","volume":"22","author":"Martindale","year":"2015","journal-title":"European J Em Med"},{"key":"10.1016\/j.ajem.2020.11.039_bb0065","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"140","author":"January","year":"2019","journal-title":"Circulation."}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720310639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720310639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:57:23Z","timestamp":1760025443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720310639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":13,"alternative-id":["S0735675720310639"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.11.039","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}